Recall Z-2428-2024
Beckman Coulter Inc. · initiated May 27, 2024
Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature
Product
Beckman Coulter, REF: OSR61173, IGM 4x14 mL R1, 4x11 mL R2
Codes / lots: UDI: 15099590011598/ All Lots: 2548/Exp. 2024-06-01, 2549/Exp.2024-10-01, 2550/Exp. 2024-11-01, 2551/Exp. 2025-04-01, 2552/Exp. 2025-07-01, 2553/Exp. 2025-10-01, 2554/ Exp. 2026-03-01
Reason for recall
LIH Influence check settings for Lipemia are incorrect which may result patient samples being reported as false low results or cause a high result to report as normal
FDA-determined cause: Process control
Action taken
On May 23, 2024, Beckman Coulter issued a "Urgent Medical Device Recall" notification via: xxx. 1. Update the LIH Influence Check settings for Lipemia on AU480, AU680, DxC 500 AU and DxC 700 AU analyzers if they are enabled for IgM. 2. To determine if the LIH Influence Check is enabled for IgM and to update your Lipemia setting, see customer communication. 3. Beckman Coulter recommends sharing the content of this letter with your laboratory and/or Medical Director to determine if a review of previous patient test results should be conducted. . Discontinuance or disposal of this product is not necessary. . Retain a copy of this letter as it serves as current labelling. . Per the IFU, avoid highly Lipemia samples when using the IgM assay. 4. Please complete the response form within 10 days in one of the following ways: - Electronically, if you received this communication via email./Manually, complete and return the enclosed Response Form. 5. If you have any questions regarding this notice, please contact our Customer Support Center: From our website: http://www.beckmancoulter.com/By phone: call 1-800-854-3633 in the United States. 6. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Details
- Recall number
- Z-2428-2024
- Initiated
- May 27, 2024
- Posted by FDA
- July 24, 2024
- Product code
- CFN – Method, Nephelometric, Immunoglobulins (G, A, M)
- Quantity
- 13,565 units
- Distribution
- Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MD, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, WA, WI, WV, WY and the countries of Albania, Algeria, Argentina, Australia, Austria, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile…
- Recalling firm
- Beckman Coulter Inc., Brea, CA